These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Satisfaction with current psoriasis treatment: misalignment between physician and patient perceptions. Korman NJ; Zhao Y; Pike J; Roberts J; Sullivan E; Kemhus M Dermatol Online J; 2016 Jul; 22(7):. PubMed ID: 27617714 [TBL] [Abstract][Full Text] [Related]
4. Assessment of medication adherence and treatment satisfaction in Japanese patients with psoriasis of various severities. Ichiyama S; Ito M; Funasaka Y; Abe M; Nishida E; Muramatsu S; Nishihara H; Kato H; Morita A; Imafuku S; Saeki H J Dermatol; 2018 Jun; 45(6):727-731. PubMed ID: 29356075 [TBL] [Abstract][Full Text] [Related]
5. Treatment patterns and perceptions of treatment attributes, satisfaction and effectiveness among patients with psoriasis. DiBonaventura Md; Wagner S; Waters H; Carter C J Drugs Dermatol; 2010 Aug; 9(8):938-44. PubMed ID: 20684144 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream. Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160 [TBL] [Abstract][Full Text] [Related]
7. Satisfaction of treatment with biologics is high in psoriasis: results from the Bio-CAPTURE network. van den Reek JM; van Lüumig PP; Otero ME; Zweegers J; van de Kerkhof PC; Ossenkoppele PM; Njoo MD; Mommers JM; Koetsier MI; Arnold WP; Sybrandy-Fleuren BA; Kuijpers AL; Andriessen MP; Seyger MM; Kievit W; de Jong EM Br J Dermatol; 2014 May; 170(5):1158-65. PubMed ID: 24484403 [TBL] [Abstract][Full Text] [Related]
8. The efficacy of a health-related quality-of-life intervention during 48 weeks of biologic treatment of patients with moderate to severe psoriasis: results of a multicentre randomized controlled trial. Prinsen CA; Spuls PI; Lindeboom R; Sprangers MA; de Rie MA; de Korte J Br J Dermatol; 2015 Oct; 173(4):1091-4. PubMed ID: 25975387 [No Abstract] [Full Text] [Related]
9. Satisfaction with treatment among patients with psoriasis: a web-based survey study. van Cranenburgh OD; de Korte J; Sprangers MA; de Rie MA; Smets EM Br J Dermatol; 2013 Aug; 169(2):398-405. PubMed ID: 23565643 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of a fixed combination of calcipotriol/betamethasone dipropionate topical gel in adult patients with mild to moderate psoriasis: blinded interim analysis of a phase IV, multicenter, randomized, controlled, prospective study. Reich K; Zschocke I; Bachelez H; de Jong EM; Gisondi P; Puig L; Warren RB; Mrowietz U; J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1156-63. PubMed ID: 25346093 [TBL] [Abstract][Full Text] [Related]
11. [Design and validation of a questionnaire to measure treatment satisfaction in patients with moderate-to-severe psoriasis: the NEODERMA study]. Ribera M; Daudén E; Puig L; Briones VG; Herranz JM; Bordas X; Vanaclocha F; Actas Dermosifiliogr; 2011 Jan; 102(1):28-38. PubMed ID: 21315859 [TBL] [Abstract][Full Text] [Related]
12. The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Al-Mutairi N; Nour T Expert Opin Biol Ther; 2014 Jun; 14(6):749-56. PubMed ID: 24661040 [TBL] [Abstract][Full Text] [Related]
13. Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey. Nijsten T; Margolis DJ; Feldman SR; Rolstad T; Stern RS J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):434-44. PubMed ID: 15761421 [TBL] [Abstract][Full Text] [Related]
14. Real-life treatment profile of calcipotriene and betamethasone dipropionate topical suspension in patients with psoriasis vulgaris. Bagel J; Levi E; Tyring S; Knuckles ML J Drugs Dermatol; 2014 Nov; 13(11):1374-9. PubMed ID: 25607705 [TBL] [Abstract][Full Text] [Related]
15. A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis. Lebwohl MG; Kircik L; Callis Duffin K; Pariser D; Hooper M; Wenkert D; Thompson EH; Yang J; Kricorian G; Koo J J Am Acad Dermatol; 2013 Sep; 69(3):385-92. PubMed ID: 23643256 [TBL] [Abstract][Full Text] [Related]
16. Clinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis: results of a European cross-sectional observational study. Christophers E; Segaert S; Milligan G; Molta CT; Boggs R J Dermatolog Treat; 2013 Jun; 24(3):193-8. PubMed ID: 22620684 [TBL] [Abstract][Full Text] [Related]
17. Patient Preferences for Treatment of Psoriasis with Biologicals: A Discrete Choice Experiment. Kromer C; Schaarschmidt ML; Schmieder A; Herr R; Goerdt S; Peitsch WK PLoS One; 2015; 10(6):e0129120. PubMed ID: 26058083 [TBL] [Abstract][Full Text] [Related]
18. Long-term adherence to topical psoriasis treatment can be abysmal: a 1-year randomized intervention study using objective electronic adherence monitoring. Alinia H; Moradi Tuchayi S; Smith JA; Richardson IM; Bahrami N; Jaros SC; Sandoval LF; Farhangian ME; Anderson KL; Huang KE; Feldman SR Br J Dermatol; 2017 Mar; 176(3):759-764. PubMed ID: 27664969 [TBL] [Abstract][Full Text] [Related]
19. Patient benefit index (PBI) in the treatment of psoriasis--results of the National Care Study "PsoHealth". Radtke MA; Schäfer I; Blome C; Augustin M Eur J Dermatol; 2013 Apr; 23(2):212-7. PubMed ID: 23587940 [TBL] [Abstract][Full Text] [Related]
20. Asian consensus on assessment and management of mild to moderate plaque psoriasis with topical therapy. Imafuku S; Zheng M; Tada Y; Zhang X; Theng C; Thevarajah S; Zhao Y; Song HJ J Dermatol; 2018 Jul; 45(7):805-811. PubMed ID: 29740870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]